DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model

DNA and Cell Biology

Volumn 18, Issue 10, 1999, Pages 771-779

  Sin, Jeong Im ^a   Bagarazzi, Mark ^a   Pachuk, Catherine ^b   Weiner, David B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WLVP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERLEUKIN 2;

ANTIBODY RESPONSE; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HELPER CELL; HERPES SIMPLEX VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, VIRAL; FEMALE; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; INTERFERON TYPE II; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; SIMPLEXVIRUS; TH1 CELLS; TH2 CELLS; VACCINATION; VACCINES, DNA; VIRAL ENVELOPE PROTEINS;

EID: 0032698408     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454999314917     Document Type: Article

References (54)

1. BOURNE, N., STANBERRY, L.R., BERNSTEIN, D.I., and LEW, D. (1996). DNA immunization against experimental genital herpes simplex virus infection. J. Infect. Dis. 173, 800-807.
2. CHATTERGOON, M., BOYER, J., and WEINER, D.B. (1997). Genetic immunization: A new era in vaccines and immune therapies. FASEB J. 11, 753-763.
3. CHOW, Y.H., CHIANG, B.L., LEE, Y.L., CHI, W.K., LIN, W.C., CHEN, Y.T., and TAO, M.H. (1998). Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J. Immunol. 160, 1320-1329.
4. CHU, R.S., TARGONI, O.S., KRIEG, A.M., LEHMANN, P.V., and HARDING, C.V. (1997). CpG oligonucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186, 1623-1631.
5. COFFMAN, R.L., SEYMOUR, B.W.P., LEBMAN, D.A., HIRAKI, D.D., CHRISTIANSEN, J.A., SHRADER, B., CHERWINSKI, H.M., SAVELKOUL, H.F.J., FINKELMAN, F.D., BOND, M.W., and MOSMANN, T.R. (1988). The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol. Rev. 102, 5-28.
6. CRUZ, P.E., KHALIL, P.L., DRYDEN, T.D., CHIOU, H.C., FINK, P.S., BERBERICH, S.J., and BIGLEY, N.J. (1999). A novel immunization method to induce cytotoxic T-lymphocyte responses (CTL) against plasmid-encoded herpes simplex virus type-1 glycoprotein D. Vaccine 17, 1091-1099.
7. EIS-HUBINGER, A.M., SCHMIDT, D.S., and SCHNEWEIS, K.E. (1993). Anti-glycoprotein B monoclonal antibody protects T cell depleted mice against herpes simplex virus by inhibition of virus replication at the inoculated mucous membrane. J. Gen. Virol. 74, 379-385.
8. FINKELMAN, F.D., HOLMES, J., KATONA, I.M., URBAN, J.F., BECKMANN, M.P., PARK, L.S., SCHOOLEY, K.A., COFFMAN, R.L., MOSMANN, T.R., and PAUL, W.E. (1990). Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8, 303-333.
9. GERMANN, T., GATELY, M.K., SCHOENHAUT, D.S., LOHOFF, M., MATTNER, F., FISCHER, S., JIN, S.C., SCHMITT, E., and RUDE, E. (1993). Interleukin-12/Tcell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells. Eur. J. Immunol. 23, 1762-1770.
10. GHIASI, H., CAI, S., SLANINA, S., NESBURN, A.B., and WECHSLER, S.L. (1995). Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge. Antiviral Res. 28, 147-157.
11. GHIASI, H., KAIWAR, R., NESBURN, A., SLANINA, S., and WECHSLER, S. (1992a). Baculovirus-expressed glycoprotein E (gE) of herpes simplex virus type-1 (HSV-1) protects mice against lethal intraperitoneal and lethal ocular HSV-1 challenge. Virology 188, 469-476.
12. GHIASI, H., KAIWAR, R., NESBURN, A., and WECHSLER, S. (1992b). Expression of herpes simplex virus type 1 glycoprotein I in baculovirus: Preliminary biochemical characterization and protection studies. J Virol. 66, 2505-2509.
13. HABU, S., AKAMATSU, K.I., TAMAOKI, N., and OKUMURA, K. (1984). In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice. J. Immunol. 133, 2743-2747.
14. HEINZEL, F.P., SADICK, M.D., HOLADAY, B.J., COFFMAN, R.L., and LOCKSLEY, R.M. (1989). Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis: Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169, 59-72.
15. IWASAKA, T., SHERIDAN, J.F., and AURELIAN, L. (1983). Immunity to herpes simplex virus type 2: Recurrent lesions are associated with the induction of suppressor cells and soluble suppressor factors. Infect. Immun. 42, 955-964.
16. JAKOB, T., WALKER, P.S., KRIEG, A.M., UDEY, M.C., and VOGEL, J.C. (1998). Activation of cutaneous dendritic cells by CpG-containing oligonucleotides: A role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161, 3042-3049.
17. KLINMAN, D.M., YAMSHCHIKOV, G., and ISHIGATSUBO, Y. (1997). Contribution of CpG motifs to the immunogenicity of DNA vaccines. 158, 3635-3639.
18. KRIESEL, J.D., SPRUANCE, S.L., DAYNES, R.A., and ARANEO, B.A. (1996). Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease. J. Infect. Dis. 173, 536-541.
19. KUHOBER, A., PUDOLLEK, H.P., REIFENBERG, K., CHISARI, F.V., SCHLICHT, H.J., REIMANN, J., and SCHIRMBECK, R. (1996). DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice. J. Immunol. 156, 3687-3695.
20. KUKLIN, N.A., DAHESHIA, M., CHUN, S., and ROUSE, B.T. (1998). Role of mucosal immunity in herpes virus infection. J. Immunol. 160, 5998-6003.
21. LAGGING, L.M., MEYER, K., HOFT, D., HOUGHTON, M., BELSHE, R.B., and RAY, R. (1995). Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J. Virol. 69, 5859-5863.
22. LECLERC, C., DERIAUD, E., ROJAS, M., and WHALEN, R.G. (1997). The preferential induction of Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA. Cell. Immunol. 179, 97-106.
23. LETVIN, N.L., MONTEFIORI, D.C., YASUTOMI, Y., PERRY, H.C., DAVIES, M.E., LEKUTIS, C., ALROY, M., FREED, D.C., LORD, C.I., HANDT, L.K., LIU, M.A., and SHIVER, J.W. (1997). Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc. Natl. Acad. Sci. USA 94, 9378-9383.
24. LONG, D., MADARA, T.J., DE LEON, M.P., COHEN, G.H., MONTGOMERY, P.C., and EISENBERG, R.J. (1984). Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2. Infect. Immun. 43, 761-764.
25. MAJOR, M.E., VITVITSKI, L., MINK, M.A., SCHLEEF, M., WHALEN, R.G., TREPO, C., and INCHAUSPE, G. (1995). DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J. Virol. 69, 5798-5805.
26. MANICKAN, E., ROUSE, R.J.D., YU, Z., WIRE, W.S., and ROUSE, B.T. (1995a). Genetic immunization against herpes simplex virus: Protection is mediated by CD4+ T lymphocytes. J. Immunol. 155, 259-265.
27. MANICKAN, E., YU, Z., ROUSE, R.J.D., WIRE, W.S., and ROUSE, B.T. (1995b). Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP 27. Viral Immunol. 8, 53-61.
28. MANSERVIGI, R., GROSSI, M.P., GUALANDRI, R., BALBONI, P.G., MARCHINI, A., ROTOLA, A., RIMESSI, P., DILUCA, D., CASSAI, E., and BARBANTI-BRODANO, G. (1990). Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein C constitutively expressed in human cells with a BK virus episomal vector. J. Virol. 64, 431-436.
29. MARTIN, S., MOSS, B., BERMAN, P.W., LASKEY, L.A., and ROUSE, B.T. (1987). Mechanisms of antiviral immunity induced by a vaccine virus recombinant expressing herpes simplex virus type 1 glycoprotein D: Cytotoxic T-cells. J. Virol. 61, 726-734.
30. MIKLOSKA, A., and CUNNINGHAM, A.L. (1998). Herpes simplex virus type 1 glycoproteins gB, gC, and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes. J. Gen. Virol. 79, 353-361.
31. MILLIGAN, G.N., and BERNSTEIN, D.I. (1995). Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2. Virology 212, 481-489.
32. MINATO, N., REID, L., CANTOR, H., LENGYEL, P., and BLOOM, B.R. (1980). Mode of regulation of natural killer cell activity by interferon. J. Exp. Med. 152, 124-137.
33. NAHMIAS, A.J., DANNENBARGER, J., WICKLIFFE, C., and MUTHER, J. (1980). Clinical aspects of infection with herpes simplex virus 1 and 2. In The Human Herpes-Viruses: An Interdisciplinary Perspective. A.J. Nahmias and R.F. Schinazi, eds. Elsevier, New York).
34. + T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J. Gen. Virol. 68, 825-833.
35. PACHUK, C.J., ARNOLD, R., HEROLD, K., CICCARELLI, R.B., and HIGGINS, T.J. (1998). Humoral and cellular immune responses to herpes simplex virus-2 glycoprotein D generated by facilitated DNA immunization of mice. Curr. Top. Microbiol. Immunol. 226, 79-89.
36. PENG, T., PONCE-DE-LEON, M., JIANG, H., DUBIN, G., LUBINSKI, J.M., EISENBERG, R.J., and COHEN, G.H. (1998). The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge. J. Virol. 72, 65-72.
37. PUTKONEN, P., QUESADA-ROLANDER, M., LEANDERSSON, A., SCHWARTZ, S., THORSTENSSON, R., OKUDA, K., WAHREN, B., and HINKULA, J. (1998). Immune responses but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinant subunit protein boosts. Virology 250, 293-301.
38. RAZ, E., TIGHE, H., SATO, Y., CORR, M., DUDLER, J.A., ROMAN, M., SWAIN, S.L., SPIEGELBERG, H.L., and CARSON, D.A. (1996). Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci. USA 93, 5141-5145.
39. ROMAN, M., MARTIN-OROZCO, E., GOODMAN, J.S., NGUYEN, M.D., SATO, Y., RONAGHY, A., KORNBLUTH, R.S., RICHMAN, D.D., CARSON, D.A., and RAZ, E. (1997). Immunostimulatory DNA sequences function as T helper-1-promoting addjuvants. Nature Med. 3, 849-854.
40. SCOTT, P., NATOVITZ, P., COFFMAN, R.L., PEARCE, E., and SHER, A. (1988). Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 168, 1675-1684.
41. SIMMONS, A., and TSCHARKE, D.C. (1992). Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: Implications for the fate of virally infected neurons. J. Exp. Med. 175, 1337-1344.
42. SIN, J.I., SUNG, J.H., SUH, Y.S. LEE, A.H., CHUNG, J.H., and SUNG, Y.C. (1997). Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: Effeet of co-injection with a granulocyte, macrophage-colony stimulating factor gene. Vaccine 15, 1827-1833.
43. SIN, J.I., KIM, J.J., UGEN, K.E., CICCARELLI, R.B., HIGGINS, T.J., and WEINER, D.B. (1998). Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte macrophage-colony stimulating factor expression cassettes. Eur. J. Immunol. 28, 3530-3540.
44. SIN, J.I., KIM, J.J., BOYER, J.D., HIGGINS, T.J., CICCARELLI, R.B., and WEINER, D.B. (1999a). In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model. J. Virol. 73, 501-509.
45. + T cell mediated protective immunity against HSV-2 challenge. J. Immunol. 162, 2912-2921.
46. SIN, J.I., AYYAVOO, V., BOYER, J., KIM, J., CICCARELLI, R., and WEINER, D.B. (1999c). Protective immune correlates can segregate by vaccine type in a murine herpes model system. Int. Immunol. 11, in press.
47. STRAUS, S.E., WALD, A., KOST, R.G., MCKENZIE, R., LANGENBERG, A.G., HOHMAN, P., LEKSTROM, I., COX, E., NAKAMURA, M., SEKULOVICH, R., IZU, A., DEKKER, C., and COREY, L. (1997). Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: Results of a placebo-controlled vaccine trial. J. Infect. Dis. 176, 1129-1134.
48. THONG, Y., VINCENT, M.M., HENSEN, S.A., FUCCELLO, D.A., ROLA-PLESZZYNSKI, M., and BELLANTI, J.A. (1975). Depressed specific cell-mediated immunity to herpes simplex virus type 1 in patients with recurrent herpes labialis. Infect. Immun. 12, 76-80.
49. + CTL clones recognize HSV-2 infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled. J. Immunol. 156, 3901-3910.
50. ULMER, J.B., DONNELLY, J., PARKER, S.E., RHODES, G.H., FELGNER, P.L., DWARKI, V.L., GROMKOWSKI, S.H., DECK, R., DEVITT, C.M., FRIEDMAN, A., HAWE, L.A., LEANDER, K.R., MARINEZ, D., PERRY, H., SHIVER, J.W., MONTGOMERY, D., and LIU, M.A. (1993). Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 159, 1745-1749.
51. WANG, B., BOYER, J.D., SRIKANTAN, V., CONEY, L., CARRANO, R., PHAN, C., MERVA, M., DANG, K., AGADJANYAN, M.G., UGEN, K.E., WILLIAMS, W.V., and WEINER, D.B. (1993a). DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and non-human primates. DNA Cell Biol. 12, 799-805.
52. WANG, B., UGEN, K.E., SRIKANTAN, V., AGADJANYAN, M.G., DANG, K., REFAELI, Y., SATO, A., BOYER, J., WILLIAMS, W.V., and WEINER, D.B. (1993b). Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90, 4156-4160.
53. XIANG, Z.Q., SPITALNIK, S., TRAN, M., WUNNER, W.H., CHENG, J., and ERTL, H.C.J. (1994). Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199, 132-140.
54. YU, Z., MANICKAN, E., and ROUSE, B.T. (1996). Role of interferon-gamma in immunity to herpes simplex virus. J. Leukocyte Biol. 60, 528-532.